Cetuximab + FOLFOX 6 as first line therapy for metastatic colorectal cancer
Jennifer L. Scott(James Cook University), Ralph V. Boccia(Center for Cancer and Blood Disorders), Christiane Pink(Universitätsmedizin Greifswald), Thomas M. Cosgriff(Oncology Specialists), Beth Butler, Shaker R. Dakhil(Cancer Center of Kansas)
Cited by 11
Related Papers
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
|Breast Cancer Research and Treatment|2017|761
Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study
|Journal of Clinical Oncology|2005|541
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia
|New England Journal of Medicine|2010|425